Tata Consultancy Services (TCS) has launched a new version of the Metadata Registry and Transformation (MRT) Platform that helps life sciences companies streamline their clinical data management by automating clinical study design and set up and conversion of clinical data into standard formats for greater interoperability across the clinical trial phases.
The MRT platform is part of TCS’ Advanced Drug Development (ADD) suite of cloud-based clinical platforms, which are powered by a cognitive engine. The latest version comes with a modernized automation engine and offers significantly enhanced capabilities across both its modules i.e Clinical Metadata Registry and Clinical Data Transformation.
TCS is an IT services, consulting and business solutions provider that has been partnering with the world’s largest businesses in their transformation journeys for the last fifty years.
